Similar approaches could conceivably extend to attempting to detect cardiac fibrosis. In CFs, protein methylation adds another dimension through PRMT5 (protein arginine methyltransferase), which ...
PRMT5 (protein arginine methyltransferase 5) and a specific gene called MTAP (metabolic enzyme 5'-deoxy-5'-methylthioadenosine phosphorylase) play important roles in cell metabolism and are ...
Zacks Investment Research on MSN2d
Bayer Licenses PRMT5 inhibitor From Suzhou Puhe BioPharmaBayer BAYRY announced a licensing agreement with Suzhou Puhe BioPharma Co., a clinical-stage biotechnology company.Suzhou Puhe BioPharma is focused on the research and development of innovative ...
Tango Therapeutics (TNGX), a biotechnology company with a market capitalization of $190 million, has been making waves in the oncology space with its focus on developing PRMT5 inhibitors for solid ...
New protein arginine N-methyltransferase 5 (PRMT5) inhibitors are detailed in a Scinnohub Pharmaceutical Co. Ltd. patent and described as potentially useful for the treatment of cancer.
The German conglomerate announced a licensing agreement with Puhe BioPharma for a PRMT5 inhibitor used in a variety of cancers. Financial details of the deal were not disclosed. German giant Bayer is ...
Oxidative Stress: Neuropathy, Excitability, and Neurodegeneration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback